Belgium· BE-AMP-SAM582586-00
BroPair Spiromax 12.75 µg - 202 µg
A salmeterol and fluticasone product containing fluticasone propionate, registered in Belgium by Teva. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Salmeterol and fluticasone is registered in 14 of 19 countries.
Countries holding a registration under ATC R03AK06 (salmeterol and fluticasone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Salmeterol and fluticasone · ATC R03AK06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fluticasone Propionate
- Manufacturer
- Teva
- Country
- Belgium (BE)
- ATC code
- R03AK06
- ATC class
- Salmeterol and fluticasone
- Defined daily dose
- 0.1 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
718 interactions on record for salmeterol and fluticasone.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Salmeterol and fluticasone · interactions on record
718 records
- 49 severe
- 397 moderate
- 24 minor
- 248 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- PindololC07AA03severe
- PropranololC07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Salmeterol and fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States24 Hour Allergy NasalWalgreen Company
- United KingdomAvamys 27.5micrograms/dose nasal sprayMawdsley-Brooks & Company Ltd
- FinlandAvamysParanova Oy
- SpainAVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASALGlaxo Group Limited
- NetherlandsCortifil 0,5 mg/g crèmeLaboratorios SALVAT, S.A.
- Japanフルチカゾンフランカルボン酸エステル東和薬品
- CzechiaAVAMYSGlaxoSmithKline Trading Services Limited, Dublin
- PolandAvamysGlaxoSmithKline (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- France · Fixorinox, Flixonase
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Ireland · Arquist, Flixonase Allergy Relief
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Netherlands · Cortifil, Cutivate
- Norway · Avamys, Flurhin
- Poland · Cutivate, Fanipos
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0ed478a-4105-40e7-9ebc-161053312a7e GET /v1/drugs/b0ed478a-4105-40e7-9ebc-161053312a7e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalation powder",
"source": "afmps",
"status": "REVOKED",
"name_en": "BroPair Spiromax 12.75 µg - 202 µg",
"name_fr": "BroPair Spiromax 12.75 µg - 202 µg",
"name_nl": "BroPair Spiromax 12.75 µg - 202 µg",
"amp_code": "SAM582586-00",
"strengths": [
"202.0000",
"202.0000",
"12.7500",
"12.7500",
"12.7500",
"5.4000"
],
"pack_count": 2,
"substances": [
"Fluticasone Propionate",
"Salmeterol",
"Salmeterol Xinafoate",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Salmeterol and Fluticasone",
"authorisation_numbers": [
"EU/1/21/1534/003",
"EU/1/21/1534/004"
]
}See everything about salmeterol and fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.